| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 26 | 2024 | 726 | 5.540 |
Why?
|
| Survivors | 21 | 2023 | 163 | 4.640 |
Why?
|
| Smoking | 12 | 2022 | 497 | 2.460 |
Why?
|
| Lung Neoplasms | 9 | 2023 | 412 | 2.320 |
Why?
|
| Head and Neck Neoplasms | 5 | 2018 | 130 | 1.980 |
Why?
|
| Smoking Cessation | 8 | 2023 | 198 | 1.940 |
Why?
|
| Breast Neoplasms | 10 | 2022 | 765 | 1.750 |
Why?
|
| Rural Population | 8 | 2020 | 274 | 1.680 |
Why?
|
| Healthcare Disparities | 8 | 2018 | 167 | 1.530 |
Why?
|
| Medical Oncology | 4 | 2019 | 86 | 1.310 |
Why?
|
| Middle Aged | 47 | 2024 | 11818 | 1.300 |
Why?
|
| Health Services Needs and Demand | 5 | 2020 | 81 | 1.270 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2019 | 19 | 1.260 |
Why?
|
| Female | 56 | 2024 | 19960 | 1.190 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 215 | 1.190 |
Why?
|
| Humans | 69 | 2024 | 32006 | 1.180 |
Why?
|
| Aged | 37 | 2024 | 10302 | 1.180 |
Why?
|
| Women's Health | 3 | 2017 | 235 | 1.180 |
Why?
|
| Quality of Life | 11 | 2023 | 946 | 1.170 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 1531 | 1.100 |
Why?
|
| Aged, 80 and over | 18 | 2020 | 3990 | 1.010 |
Why?
|
| Health Behavior | 4 | 2024 | 232 | 1.010 |
Why?
|
| Adult | 32 | 2024 | 9346 | 0.980 |
Why?
|
| Delivery of Health Care | 4 | 2021 | 160 | 0.980 |
Why?
|
| Male | 43 | 2024 | 19166 | 0.960 |
Why?
|
| Urban Population | 6 | 2019 | 89 | 0.950 |
Why?
|
| Adaptation, Psychological | 7 | 2018 | 138 | 0.950 |
Why?
|
| Caregivers | 3 | 2018 | 114 | 0.940 |
Why?
|
| Health Status Disparities | 4 | 2015 | 123 | 0.930 |
Why?
|
| Stress, Psychological | 7 | 2018 | 221 | 0.890 |
Why?
|
| Mental Health | 2 | 2016 | 117 | 0.890 |
Why?
|
| Health Promotion | 3 | 2016 | 246 | 0.870 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 49 | 0.860 |
Why?
|
| United States | 17 | 2019 | 3939 | 0.850 |
Why?
|
| Health Services Accessibility | 5 | 2013 | 241 | 0.820 |
Why?
|
| Needs Assessment | 2 | 2020 | 76 | 0.790 |
Why?
|
| Attitude to Health | 3 | 2017 | 165 | 0.780 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 471 | 0.780 |
Why?
|
| Quality of Health Care | 3 | 2020 | 147 | 0.750 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 1128 | 0.740 |
Why?
|
| Primary Health Care | 3 | 2018 | 227 | 0.630 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 301 | 0.610 |
Why?
|
| Early Detection of Cancer | 5 | 2023 | 90 | 0.610 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 271 | 0.600 |
Why?
|
| Models, Theoretical | 3 | 2009 | 137 | 0.590 |
Why?
|
| Radiology | 1 | 2017 | 41 | 0.570 |
Why?
|
| Health Services Research | 1 | 2017 | 82 | 0.570 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2006 | 29 | 0.560 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 183 | 0.530 |
Why?
|
| Biomedical Research | 1 | 2017 | 156 | 0.530 |
Why?
|
| Rest | 1 | 2015 | 53 | 0.520 |
Why?
|
| Self Disclosure | 1 | 2015 | 22 | 0.510 |
Why?
|
| Neural Pathways | 1 | 2015 | 94 | 0.510 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 185 | 0.500 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 10 | 0.500 |
Why?
|
| Brain Mapping | 1 | 2015 | 178 | 0.490 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 117 | 0.490 |
Why?
|
| Disability Evaluation | 1 | 2016 | 240 | 0.490 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 154 | 0.480 |
Why?
|
| Health Expenditures | 3 | 2015 | 66 | 0.480 |
Why?
|
| Patients | 2 | 2012 | 46 | 0.470 |
Why?
|
| Counseling | 5 | 2021 | 97 | 0.460 |
Why?
|
| Patient Participation | 1 | 2014 | 82 | 0.460 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 158 | 0.460 |
Why?
|
| Treatment Refusal | 1 | 2013 | 11 | 0.450 |
Why?
|
| Health Personnel | 3 | 2021 | 121 | 0.450 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 390 | 0.440 |
Why?
|
| Health Status | 6 | 2018 | 399 | 0.440 |
Why?
|
| Communication | 1 | 2014 | 142 | 0.440 |
Why?
|
| Mental Disorders | 1 | 2014 | 121 | 0.430 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 36 | 0.430 |
Why?
|
| Tamoxifen | 1 | 2013 | 59 | 0.430 |
Why?
|
| Medication Adherence | 2 | 2021 | 161 | 0.420 |
Why?
|
| Ethnic Groups | 3 | 2018 | 476 | 0.410 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 367 | 0.400 |
Why?
|
| Continental Population Groups | 1 | 2013 | 237 | 0.390 |
Why?
|
| HIV Seropositivity | 3 | 2006 | 14 | 0.390 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 353 | 0.380 |
Why?
|
| Tobacco Use Disorder | 2 | 2010 | 84 | 0.380 |
Why?
|
| Child of Impaired Parents | 1 | 2010 | 3 | 0.370 |
Why?
|
| Mass Screening | 3 | 2019 | 263 | 0.360 |
Why?
|
| Adolescent | 9 | 2015 | 3539 | 0.360 |
Why?
|
| Self Efficacy | 2 | 2014 | 78 | 0.350 |
Why?
|
| Postoperative Complications | 1 | 2015 | 780 | 0.350 |
Why?
|
| Minority Groups | 2 | 2022 | 78 | 0.340 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 34 | 0.330 |
Why?
|
| Age Factors | 4 | 2019 | 1188 | 0.330 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 245 | 0.320 |
Why?
|
| Viral Load | 2 | 2006 | 70 | 0.320 |
Why?
|
| Brain | 1 | 2015 | 951 | 0.320 |
Why?
|
| Maternal Behavior | 1 | 2008 | 3 | 0.320 |
Why?
|
| Treatment Outcome | 8 | 2017 | 3306 | 0.290 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 105 | 0.290 |
Why?
|
| Patient Compliance | 2 | 2006 | 225 | 0.280 |
Why?
|
| Risk Factors | 6 | 2015 | 3876 | 0.270 |
Why?
|
| Ethics, Nursing | 1 | 2006 | 1 | 0.270 |
Why?
|
| Philosophy, Nursing | 1 | 2006 | 1 | 0.270 |
Why?
|
| Models, Nursing | 1 | 2006 | 2 | 0.270 |
Why?
|
| Concept Formation | 1 | 2006 | 3 | 0.270 |
Why?
|
| Nursing Evaluation Research | 1 | 2006 | 5 | 0.270 |
Why?
|
| European Continental Ancestry Group | 4 | 2015 | 1166 | 0.260 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 75 | 0.260 |
Why?
|
| Socioeconomic Factors | 6 | 2014 | 423 | 0.260 |
Why?
|
| Patient Satisfaction | 4 | 2018 | 240 | 0.260 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 608 | 0.250 |
Why?
|
| Anorexia Nervosa | 1 | 2005 | 2 | 0.250 |
Why?
|
| Cotinine | 2 | 2015 | 49 | 0.250 |
Why?
|
| Depression | 3 | 2023 | 444 | 0.250 |
Why?
|
| Data Collection | 3 | 2018 | 180 | 0.250 |
Why?
|
| Logistic Models | 4 | 2014 | 781 | 0.240 |
Why?
|
| Lung | 2 | 2023 | 249 | 0.230 |
Why?
|
| Health Surveys | 2 | 2016 | 196 | 0.230 |
Why?
|
| Self Care | 1 | 2005 | 144 | 0.230 |
Why?
|
| Anxiety | 2 | 2023 | 191 | 0.220 |
Why?
|
| Specialization | 2 | 2014 | 31 | 0.220 |
Why?
|
| Qualitative Research | 1 | 2024 | 168 | 0.220 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 20 | 0.220 |
Why?
|
| Dyspnea | 1 | 2023 | 33 | 0.210 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 18 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2023 | 293 | 0.200 |
Why?
|
| Radiation Injuries | 1 | 2022 | 76 | 0.200 |
Why?
|
| Motivation | 1 | 2022 | 112 | 0.200 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 2265 | 0.190 |
Why?
|
| Social Support | 3 | 2014 | 181 | 0.190 |
Why?
|
| Comorbidity | 3 | 2014 | 566 | 0.190 |
Why?
|
| Appalachian Region | 1 | 2020 | 17 | 0.180 |
Why?
|
| Guideline Adherence | 1 | 2021 | 119 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2024 | 545 | 0.180 |
Why?
|
| Decision Making | 2 | 2014 | 195 | 0.170 |
Why?
|
| California | 3 | 2014 | 62 | 0.170 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 217 | 0.170 |
Why?
|
| HIV Infections | 1 | 2004 | 394 | 0.170 |
Why?
|
| African Americans | 3 | 2015 | 1425 | 0.160 |
Why?
|
| Young Adult | 3 | 2015 | 2636 | 0.160 |
Why?
|
| Prevalence | 3 | 2017 | 981 | 0.160 |
Why?
|
| Physicians | 2 | 2012 | 158 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2022 | 2282 | 0.160 |
Why?
|
| Hispanic Americans | 3 | 2014 | 940 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2017 | 26 | 0.150 |
Why?
|
| Medically Underserved Area | 1 | 2017 | 23 | 0.150 |
Why?
|
| Hostility | 1 | 2017 | 4 | 0.150 |
Why?
|
| Cardiac Volume | 1 | 2017 | 13 | 0.140 |
Why?
|
| Obesity | 3 | 2014 | 1175 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 81 | 0.140 |
Why?
|
| Florida | 2 | 2008 | 37 | 0.140 |
Why?
|
| Prognosis | 3 | 2017 | 1497 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2018 | 185 | 0.140 |
Why?
|
| Demography | 1 | 2016 | 109 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2017 | 135 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 170 | 0.130 |
Why?
|
| False Negative Reactions | 1 | 2015 | 20 | 0.130 |
Why?
|
| Postmenopause | 1 | 2017 | 430 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2013 | 472 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 447 | 0.120 |
Why?
|
| Shame | 1 | 2014 | 3 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2015 | 84 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 1328 | 0.120 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 108 | 0.120 |
Why?
|
| Long-Term Care | 1 | 2014 | 25 | 0.120 |
Why?
|
| Resilience, Psychological | 1 | 2014 | 18 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 308 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 226 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 48 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2017 | 348 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 918 | 0.110 |
Why?
|
| Life Style | 2 | 2013 | 408 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2014 | 22 | 0.110 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 12 | 0.110 |
Why?
|
| Length of Stay | 1 | 2015 | 314 | 0.110 |
Why?
|
| Radiography | 1 | 2015 | 376 | 0.110 |
Why?
|
| Health Services | 1 | 2014 | 38 | 0.110 |
Why?
|
| Yoga | 1 | 2014 | 50 | 0.110 |
Why?
|
| Quinazolines | 1 | 2013 | 38 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2013 | 11 | 0.110 |
Why?
|
| National Health Programs | 1 | 2013 | 4 | 0.110 |
Why?
|
| Menopause | 1 | 2014 | 95 | 0.110 |
Why?
|
| Refusal to Participate | 1 | 2013 | 4 | 0.110 |
Why?
|
| Patient Preference | 1 | 2013 | 47 | 0.110 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 26 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2013 | 17 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 57 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 762 | 0.110 |
Why?
|
| Aftercare | 1 | 2013 | 33 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 101 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2014 | 191 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 94 | 0.110 |
Why?
|
| Time Factors | 3 | 2017 | 2149 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2013 | 293 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 190 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 91 | 0.100 |
Why?
|
| Poverty | 1 | 2013 | 111 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 78 | 0.100 |
Why?
|
| Exercise | 2 | 2018 | 672 | 0.100 |
Why?
|
| Outpatients | 1 | 2012 | 57 | 0.100 |
Why?
|
| Psychology | 2 | 2008 | 24 | 0.100 |
Why?
|
| Patient Selection | 1 | 2013 | 276 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 638 | 0.090 |
Why?
|
| Population Groups | 1 | 2010 | 7 | 0.090 |
Why?
|
| Leukemia | 1 | 2009 | 40 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 411 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 946 | 0.080 |
Why?
|
| African Continental Ancestry Group | 1 | 2010 | 363 | 0.080 |
Why?
|
| Social Class | 1 | 2009 | 89 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2013 | 1817 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 23 | 0.080 |
Why?
|
| Causality | 1 | 2008 | 38 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2010 | 671 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 92 | 0.070 |
Why?
|
| Infant | 1 | 2010 | 1061 | 0.070 |
Why?
|
| Social Adjustment | 1 | 2006 | 9 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 192 | 0.070 |
Why?
|
| Attitude | 1 | 2006 | 40 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 220 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2010 | 1269 | 0.070 |
Why?
|
| HIV-1 | 1 | 2006 | 45 | 0.070 |
Why?
|
| SEER Program | 2 | 2018 | 30 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 47 | 0.070 |
Why?
|
| Morals | 1 | 2006 | 4 | 0.070 |
Why?
|
| Nurse's Role | 1 | 2006 | 8 | 0.070 |
Why?
|
| Knowledge | 1 | 2006 | 14 | 0.070 |
Why?
|
| Nurse-Patient Relations | 1 | 2006 | 4 | 0.070 |
Why?
|
| Uncertainty | 1 | 2006 | 10 | 0.070 |
Why?
|
| Comprehension | 1 | 2006 | 19 | 0.070 |
Why?
|
| Hypertension | 1 | 2013 | 959 | 0.070 |
Why?
|
| Empathy | 1 | 2006 | 18 | 0.070 |
Why?
|
| Affect | 1 | 2006 | 69 | 0.060 |
Why?
|
| Cues | 1 | 2006 | 68 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 109 | 0.060 |
Why?
|
| Feminism | 1 | 2005 | 1 | 0.060 |
Why?
|
| Obsessive Behavior | 1 | 2005 | 3 | 0.060 |
Why?
|
| Psychological Theory | 1 | 2005 | 6 | 0.060 |
Why?
|
| Psychology, Social | 1 | 2005 | 2 | 0.060 |
Why?
|
| Pregnancy | 1 | 2008 | 997 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 317 | 0.060 |
Why?
|
| Homosexuality, Male | 1 | 2005 | 84 | 0.060 |
Why?
|
| Models, Biological | 1 | 2006 | 392 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2005 | 103 | 0.060 |
Why?
|
| Spirituality | 1 | 2004 | 37 | 0.060 |
Why?
|
| Child | 1 | 2010 | 2438 | 0.060 |
Why?
|
| Research Design | 1 | 2006 | 313 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 83 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 767 | 0.050 |
Why?
|
| Telemedicine | 1 | 2024 | 102 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2022 | 27 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2022 | 78 | 0.050 |
Why?
|
| Mastectomy | 1 | 2022 | 64 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 172 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2021 | 187 | 0.050 |
Why?
|
| Registries | 2 | 2014 | 298 | 0.040 |
Why?
|
| Cognition | 1 | 2004 | 555 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 684 | 0.040 |
Why?
|
| Gender Identity | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 70 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2018 | 108 | 0.040 |
Why?
|
| Diastole | 1 | 2017 | 96 | 0.040 |
Why?
|
| Medicare | 1 | 2018 | 206 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 103 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 483 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 407 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 56 | 0.030 |
Why?
|
| Narration | 1 | 2014 | 18 | 0.030 |
Why?
|
| Self Concept | 1 | 2014 | 43 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 75 | 0.030 |
Why?
|
| Los Angeles | 1 | 2014 | 7 | 0.030 |
Why?
|
| Filgrastim | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Survival | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Missouri | 1 | 2013 | 21 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 24 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 64 | 0.030 |
Why?
|
| Cisplatin | 1 | 2013 | 76 | 0.030 |
Why?
|
| Taxoids | 1 | 2013 | 59 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2017 | 356 | 0.030 |
Why?
|
| North Carolina | 1 | 2018 | 1514 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 85 | 0.030 |
Why?
|
| Research Subjects | 1 | 2013 | 17 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 247 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 276 | 0.030 |
Why?
|
| Overweight | 1 | 2014 | 280 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 923 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 881 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 78 | 0.020 |
Why?
|
| Tobacco | 1 | 2010 | 57 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 458 | 0.020 |
Why?
|
| Chicago | 1 | 2009 | 10 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 137 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3509 | 0.020 |
Why?
|
| Illinois | 1 | 2007 | 10 | 0.020 |
Why?
|
| Electronics | 1 | 2006 | 14 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2006 | 19 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2006 | 26 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2006 | 97 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 264 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 495 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 1199 | 0.010 |
Why?
|